Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto
Background: The incidence of central nervous system (CNS) metastases in breast cancer patients is rising and has become a major clinical challenge. Only few data are published concerning risk factors for the development of CNS metastases as a first site of metastatic disease in breast cancer patient...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019
|
| In: |
Breast cancer research
Year: 2019, Volume: 21, Pages: 1-8 |
| ISSN: | 1465-542X |
| DOI: | 10.1186/s13058-019-1144-x |
| Online Access: | Verlag, Volltext: https://doi.org/10.1186/s13058-019-1144-x Verlag, Volltext: https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-019-1144-x 
|
| Author Notes: | Elena Laakmann, Isabell Witzel, Peter A. Fasching, Mahdi Rezai, Christian Schem, Christine Solbach, Hans Tesch, Peter Klare, Andreas Schneeweiss, Christoph Salat, Dirk-Michael Zahm, Jens-Uwe Blohmer, Barbara Ingold-Heppner, Jens Huober, Claus Hanusch, Christian Jackisch, Mattea Reinisch, Michael Untch, Gunter von Minckwitz, Valentina Nekljudova, Volkmar Müller and Sibylle Loibl |
Search Result 1
Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto
BioMed Central 01 Aug. 2019 Universitätsbibliothek Heidelberg 01 Aug. 2019
Article (Journal)
Book/Monograph
Online Resource